CEO Brian Roney Buys $50.6K of Presurance Stock at $6.75
PRHI sits 99% above its 52-week low of $3.361.
Summary
CEO Brian Roney bought $50.6K of Presurance stock at $6.75 per share, raising his direct stake to 80,390 shares. This follows the CFO's $26.1K purchase the same day.
Key Events · Ownership and Investor Activity · PRHI
-
CEO Open-Market Purchase
CEO Brian J. Roney bought 7,500 shares at $6.75 per share for $50,622.75 on September 30, 2026, raising direct holdings to 80,390 shares.
-
Insider Buying Cluster
This purchase follows CFO Harold Meloche's $26,138 purchase at $6.38 on the same day, totaling $76,760 in same-day insider buying.
-
Post-Split Adjusted Holdings
All share counts reflect the 1-for-7 reverse stock split effective June 1, 2026, per the filing footnote.
Analysis · PRHI · Finance
CEO Brian Roney bought 7,500 shares at $6.75 per share for $50,622.75 on September 30, 2026, raising his direct stake to 80,390 shares. This is a real-money open-market purchase, not an option exercise or grant. It follows CFO Harold Meloche's $26,138 purchase at $6.38 on the same day, creating a cluster of insider buying. The combined $76,760 in same-day insider purchases is a notable confidence signal for a nano-cap insurer.
How filings like this one have moved
In the 30 days to Oct 1, 2026, 30.2% of the 1605 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.53%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, PRHI was trading at $6.70 on NASDAQ in the Finance sector, with a market capitalization of approximately $25.1M. The 52-week trading range was $3.36 to $19.81. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.